Beyond COVID-19: Ousted BARDA Chief’s Whistleblower Complaint Suggests Widespread Politicization of HHS Funding Decisions

 
• By Sarah Karlin-Smith

Ousted BARDA Director Rick Bright's whistleblower complaint cites a long-pattern of political interference in scientific decisions making and could lead to overhauls in how BARDA and other HHS contracts are awarded to the drug industry. It could also impact how Congress funds BARDA, following a recent move by lawmakers to give the division more direct control of its funding.     

Antique cash register - Image
Bright's whistle blower complaint claims that politically connected firms were cashing in on government contracts.

More from Legislation

More from Pink Sheet